These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 38252041)

  • 41. Transmission dynamics and effect of control measures on the 2022 outbreak of mpox among gay, bisexual, and other men who have sex with men in England: a mathematical modelling study.
    Zhang XS; Mandal S; Mohammed H; Turner C; Florence I; Walker J; Niyomsri S; Amirthalingam G; Ramsay M; Charlett A; Vickerman P
    Lancet Infect Dis; 2024 Jan; 24(1):65-74. PubMed ID: 37708908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of mpox positive, versus mpox negative, and mpox unsuspected clients from the Centre of Sexual Health, Public Health Service of Amsterdam, 20 May to 15 September 2022.
    Siegenbeek van Heukelom ML; Jongen VW; Schouten J; Hoornenborg E; Bruisten S; Westerhuis B; Welkers MR; Vergunst CE; Prins M; Schim van der Loeff MF; de Vries HJC
    J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1891-1896. PubMed ID: 37212540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to the Female Sex at Birth: A Comprehensive, Critical Global Perspective.
    Bragazzi NL; Woldegerima WA; Wu J; Converti M; Szarpak L; Crapanzano A; Odeh M; Farah R; Khamisy-Farah R
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative analysis of viral infection outcomes in human seminal fluid from prior viral epidemics and Sars-CoV-2 may offer trends for viral sexual transmissibility and long-term reproductive health implications.
    Pike JFW; Polley EL; Pritchett DY; Lal A; Wynia BA; Roudebush WE; Chosed RJ
    Reprod Health; 2021 Jun; 18(1):123. PubMed ID: 34112171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Underdetected dispersal and extensive local transmission drove the 2022 mpox epidemic.
    Paredes MI; Ahmed N; Figgins M; Colizza V; Lemey P; McCrone JT; Müller N; Tran-Kiem C; Bedford T
    Cell; 2024 Mar; 187(6):1374-1386.e13. PubMed ID: 38428425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic Response.
    Raccagni AR; Mancon A; Diotallevi S; Lolatto R; Bruzzesi E; Gismondo MR; Castagna A; Mileto D; Nozza S
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV viral load monitoring during monkeypox virus infection among people with HIV.
    Raccagni AR; Mileto D; Galli L; Bruzzesi E; Canetti D; Rizzo A; Bertoni C; Clemente T; Alberton F; Castagna A; Nozza S
    AIDS; 2023 Apr; 37(5):779-783. PubMed ID: 36689645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans.
    Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S
    Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tecovirimat Resistance in Mpox Patients, United States, 2022-2023.
    Smith TG; Gigante CM; Wynn NT; Matheny A; Davidson W; Yang Y; Condori RE; O'Connell K; Kovar L; Williams TL; Yu YC; Petersen BW; Baird N; Lowe D; Li Y; Satheshkumar PS; Hutson CL
    Emerg Infect Dis; 2023 Dec; 29(12):2426-2432. PubMed ID: 37856204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability of Monkeypox Virus in Body Fluids and Wastewater.
    Yinda CK; Morris DH; Fischer RJ; Gallogly S; Weishampel ZA; Port JR; Bushmaker T; Schulz JE; Bibby K; van Doremalen N; Lloyd-Smith JO; Munster VJ
    Emerg Infect Dis; 2023 Oct; 29(10):2065-2072. PubMed ID: 37735747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current Evidence and Practice Guidelines of Systemic Complications of 2022 Mpox Outbreak: A Scoping Review.
    Ajmera K; Shah H; Chourasia P; Chitturi S
    Cureus; 2023 Sep; 15(9):e45754. PubMed ID: 37771934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiologic characteristics and clinical features of patients with monkeypox virus infection from a hospital in Peru between July and September 2022.
    Sihuincha Maldonado M; Lucchetti AJ; Paredes Pacheco RA; Martínez Cevallos LC; Zumaeta Saavedra EU; Ponce Zapata LR; Lizarbe Huayta FA; Matos Prado ED
    Int J Infect Dis; 2023 Apr; 129():175-180. PubMed ID: 36740013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models.
    Cinatl J; Bechtel M; Reus P; Ott M; Rothweiler F; Michaelis M; Ciesek S; Bojkova D
    J Med Virol; 2024 Jan; 96(1):e29354. PubMed ID: 38180134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring monkeypox virus proteins and rapid detection techniques.
    Sagdat K; Batyrkhan A; Kanayeva D
    Front Cell Infect Microbiol; 2024; 14():1414224. PubMed ID: 38863833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphofollicular lesions associated with monkeypox (Mpox) virus proctitis.
    Mazzotta V; Scorzolini L; Falasca L; Lionetti R; Aguglia C; Kontogiannis D; Colombo D; Colavita F; De Palo MG; Carletti F; Mondi A; Pinnetti C; Maffongelli G; Garbuglia AR; Baldini F; Corpolongo A; Maggi F; D'Offizi G; Girardi E; Vaia F; Nicastri E; Del Nonno F; Antinori A
    Int J Infect Dis; 2023 May; 130():48-51. PubMed ID: 36858309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
    De Clercq E; Jiang Y; Li G
    Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation and clinical validation of monkeypox (mpox) virus real-time PCR assays.
    Mills MG; Juergens KB; Gov JP; McCormick CJ; Sampoleo R; Kachikis A; Amory JK; Fang FC; Pérez-Osorio AC; Lieberman NAP; Greninger AL
    J Clin Virol; 2023 Feb; 159():105373. PubMed ID: 36603329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and Pilot of an Mpox Severity Scoring System.
    Zucker J; McLean J; Huang S; DeLaurentis C; Gunaratne S; Stoeckle K; Glesby MJ; Wilkin TJ; Fischer W; Damon I; Brooks JT
    J Infect Dis; 2024 Mar; 229(Supplement_2):S229-S233. PubMed ID: 37956401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Egocentric sexual network analysis among gay and bisexual men who have sex with men with and without mpox infection.
    Sönmez İ; Martínez Riveros H; Folch C; Suñer C; Díaz Y; Alonso L; Agusti C; Mendoza A; Tarín-Vicente EJ; Oller X; Alemany A; Rivero À; Orviz E; Silva-Klug A; Mitjà O; Casabona J;
    Sex Transm Infect; 2023 Dec; 99(8):541-547. PubMed ID: 37704363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mpox Virus: Control of In-Hospital Occupational Transmission Experience from a Tertiary Level Hospital in Milan, Italy.
    Raccagni AR; Gianotti N; Moro M; Mileto D; Gordo Perez V; Castagna A; Nozza S
    Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.